2025-03-08

#reports #OFLX

[Omega Flex](https://eninvs.com/all.php?name=OFLX) (Specialty Industrial Machinery) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181996)
(2025-02-06, After Market Close):

- Revenue -3.6% YoY (vs -7.4% in previous quarter and historical rate -7.5%)
- EBITDA 0% YoY (vs -14.3% in previous quarter and historical rate -13.9%)
- EBITDA margin 22.2% increased compared to 21.4% same period last year
- Net Debt decreased by $6 mln over the past reporting period (1.5% of market cap)
- EV/EBITDA multiple is 14.7x compared to historical level (75th percentile) of 29.5x
- EV/Sales multiple is 3.3x

At the opening of the session the share price went down -0.1% vs S&P500 +0.2%

------------------------------------------------

2025-03-08

#reports #MASS

[908 Devices Inc.](https://eninvs.com/all.php?name=MASS) (Medical Devices) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182005)
(2025-03-04, Before Market Open):

- Revenue +35.7% YoY (vs +21.4% in previous quarter and historical rate +23.4%)
- EBITDA margin -94.7% increased compared to -128.6% same period last year
- Net Debt increased by $6 mln over the past reporting period (6.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 74.2% of market cap
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +79.5% vs S&P500 -0.3%

------------------------------------------------

2025-03-08

#reports #AXR

[AMREP Corporation](https://eninvs.com/all.php?name=AXR) (Real Estate — Development) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182021)
(2024-12-10, After Market Close):

- Revenue -38.5% YoY (vs +33.3% in previous quarter and historical rate +9.7%)
- EV/EBITDA multiple is 9.2x compared to historical level (75th percentile) of 17x
- EV/Sales multiple is 2x

At the opening of the session the share price went down -0.5% vs S&P500 +0.5%

------------------------------------------------

2025-03-08

#reports #TKNO

[Alpha Teknova, Inc.](https://eninvs.com/all.php?name=TKNO) (Drug Manufacturers — Specialty and Generic) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181989)
(2025-03-04, After Market Close):

- Revenue +12.5% YoY (vs +25.0% in previous quarter and historical rate +4.2%)
- EBITDA margin -66.7% increased compared to -300.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 1.8% of market cap
- EV/Sales multiple is 4.5x

At the opening of the session the share price went up +9.6% vs S&P500 -0.4%

------------------------------------------------

2025-03-08

#reports #SNBR

[Sleep Number](https://eninvs.com/all.php?name=SNBR) (Bed manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181987)
(2025-03-05, After Market Close):

- Revenue +192.1% YoY (vs -9.7% in previous quarter and historical rate +9.1%)
- EBITDA margin 3.7% increased compared to -0.2% same period last year
- Net Debt increased by $18 mln over the past reporting period (10.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 32.2% of market cap
- EV/EBITDA multiple is 9.4x compared to historical level (75th percentile) of 16x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went down -22.4% vs S&P500 -1.0%

------------------------------------------------

2025-03-08

#reports #INTT

[inTEST Corporation](https://eninvs.com/all.php?name=INTT) (Semiconductor Equipment and Materials) reported for 2024 q4
(2025-03-07, Before Market Open):

- Revenue +32.1% YoY (vs -9.1% in previous quarter and historical rate +17.2%)
- EBITDA +50% YoY (vs -50.0% in previous quarter)
- EBITDA margin 8.1% increased compared to 7.1% same period last year
- Net Debt decreased by $4 mln over the past reporting period (4.2% of market cap)
- FCF (LTM) -$0 bln (negative), 34.8% of market cap
- EV/EBITDA multiple is 11.2x compared to historical level (75th percentile) of 12.9x
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +16.1% vs S&P500 -0.4%

------------------------------------------------

2025-03-08

#reports #DAIO

[Data I/O Corporation](https://eninvs.com/all.php?name=DAIO) (Electronic Components) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=8&id=89192)
(2025-02-27, After Market Close):

- Revenue -28.6% YoY (vs -28.6% in previous quarter and historical rate -4.0%)
- Net Debt increased by $3 mln over the past reporting period (13.7% of market cap)
- FCF (LTM) -$0 bln (negative), 4.6% of market cap
- EV/EBITDA multiple is 13.9x compared to historical level (75th percentile) of 14x
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -0.7% vs S&P500 -0.3%

------------------------------------------------

2025-03-08

#reports #CMCT

[CIM Commercial Trust Corporation](https://eninvs.com/all.php?name=CMCT) (REIT — Office) reported for 2024 q4
(2024-11-08, Before Market Open):

- Revenue -6.9% YoY (vs +3.6% in previous quarter and historical rate +11.3%)
- EBITDA -10% YoY (vs -40.7% in previous quarter and historical rate +44.5%)
- EBITDA margin 66.7% decreased compared to 69.0% same period last year
- EV/Sales multiple is 0x

At the opening of the session the share price went neutrally vs S&P500 -0.1%

------------------------------------------------

2025-03-07

#reports #XTNT

[Xtant Medical](https://eninvs.com/all.php?name=XTNT) (Medical Devices) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181924)
(2025-03-06, After Market Close):

- Revenue +14.3% YoY (vs +12.0% in previous quarter and historical rate +31.3%)
- EBITDA margin -3.1% increased compared to -10.7% same period last year
- EV/Sales multiple is 0.8x

At the opening of the session the share price went neutrally

------------------------------------------------

2025-03-07

#reports #VHI

[Valhi](https://eninvs.com/all.php?name=VHI) (Chemicals) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181922)
(2025-03-06, After Market Close):

- Revenue +30.4% YoY (vs +1.9% in previous quarter and historical rate +0.4%)
- EBITDA +712.5% YoY (vs +454.5% in previous quarter and historical rate +44.2%)
- EBITDA margin 30.5% increased compared to 4.9% same period last year
- Net Debt decreased by $83 mln over the past reporting period (17.9% of market cap)
- FCF (LTM) -$0.2 bln (negative), 49.5% of market cap
- EV/EBITDA multiple is 2.9x compared to historical level (75th percentile) of 12.8x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +0.4%

------------------------------------------------

2025-03-07

#reports #TPB

[Turning Point Brands](https://eninvs.com/all.php?name=TPB) (Tobacco products producer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=8&id=84848)
(2025-03-06, Before Market Open):

- Revenue -34% YoY (vs +8.3% in previous quarter and historical rate -6.5%)
- EBITDA -24% YoY (vs 0.0% in previous quarter and historical rate +1.7%)
- EBITDA margin 29.7% increased compared to 25.8% same period last year
- Net Debt decreased by $283 mln over the past reporting period (26.1% of market cap)
- FCF (LTM) -$0 bln (negative), 2.0% of market cap
- EV/EBITDA multiple is 16.1x compared to historical level (75th percentile) of 10.3x
- EV/Sales multiple is 3.8x

At the opening of the session the share price went down -2.9% vs S&P500 -1.0%

------------------------------------------------

2025-03-07

#reports #SUP

[Superior Industries International](https://eninvs.com/all.php?name=SUP) (Auto Parts) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181917)
(2025-03-06, Before Market Open):

- Revenue +0.3% YoY (vs -0.3% in previous quarter and historical rate +4.5%)
- EBITDA +775% YoY (vs +2500.0% in previous quarter and historical rate +14.9%)
- EBITDA margin 11.3% increased compared to 1.3% same period last year
- Net Debt increased by $445 mln over the past reporting period (766.4% of market cap)
- FCF (LTM) -$0.4 bln (negative), 766.4% of market cap
- EV/EBITDA multiple is 6.6x compared to historical level (75th percentile) of 3.9x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went up +7.8% vs S&P500 -1.0%

------------------------------------------------

2025-03-07

#reports #SAMG

[Silvercrest Asset Management Group](https://eninvs.com/all.php?name=SAMG) (Asset Management) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181916)
(2025-03-06, Before Market Open):

- Revenue +10.3% YoY (vs 0.0% in previous quarter and historical rate -1.7%)
- Net Income margin 9.4% increased compared to -3.4% same period last year
- P/E multiple is 10.4x compared to historical level (75th percentile) of 11.6x
- P/S multiple is 1.4x
- Price to book: 2x

At the opening of the session the share price went down -1.2% vs S&P500 -1.0%

------------------------------------------------

2025-03-07

#reports #PRTH

[Priority Technology](https://eninvs.com/all.php?name=PRTH) (Software — Infrastructure) reported for 2024 q4
(2025-03-06, Before Market Open):

- Revenue +14.1% YoY (vs +20.1% in previous quarter and historical rate +19.9%)
- EBITDA +19.6% YoY (vs +27.9% in previous quarter)
- EBITDA margin 78.0% increased compared to 74.4% same period last year
- Net Debt increased by $58 mln over the past reporting period (9.6% of market cap)
- FCF (LTM) -$0.2 bln (negative), 27.5% of market cap
- EV/EBITDA multiple is 4.8x compared to historical level (75th percentile) of 32.4x
- EV/Sales multiple is 3.8x

At the opening of the session the share price went down -4.7% vs S&P500 -1.0%

------------------------------------------------

2025-03-07

#reports #PBPB

[Potbelly Corporation](https://eninvs.com/all.php?name=PBPB) (Restaurants) reported for 2024 q4
(2025-03-06, After Market Close):

- Revenue -7.1% YoY (vs -5.0% in previous quarter and historical rate +7.6%)
- EBITDA -14.3% YoY (vs +16.7% in previous quarter and historical rate +80.6%)
- EBITDA margin 5.1% decreased compared to 5.6% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 2.8% of market cap
- EV/EBITDA multiple is 15x compared to historical level (75th percentile) of 15.6x
- EV/Sales multiple is 1.1x

------------------------------------------------

2025-03-07

#reports #NL

[NL Industries](https://eninvs.com/all.php?name=NL) (Security and Protection Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181913)
(2025-03-05, After Market Close):

- Revenue -11.6% YoY (vs -15.0% in previous quarter and historical rate +2.0%)
- EBITDA +138.1% YoY (vs -43.8% in previous quarter and historical rate -1.9%)
- EBITDA margin 131.6% increased compared to 48.8% same period last year
- Net Debt increased by $127 mln over the past reporting period (37.2% of market cap)
- FCF (LTM) -$0 bln (negative), 4.4% of market cap
- EV/EBITDA multiple is 3.1x compared to historical level (75th percentile) of 4.1x
- EV/Sales multiple is 1.5x

At the opening of the session the share price went up +2.2% vs S&P500 -1.0%

------------------------------------------------

2025-03-07

#reports #NEPH

[Nephros](https://eninvs.com/all.php?name=NEPH) (Medical Instruments and Supplies) reported for 2024 q4
(2025-03-03, After Market Close):

- Revenue +33.3% YoY (vs 0.0% in previous quarter and historical rate +20.1%)
- Net Debt decreased by $1 mln over the past reporting period (6.5% of market cap)
- FCF (LTM) +$0 bln (positive), 6.5% of market cap
- EV/Sales multiple is 0.8x

------------------------------------------------

2025-03-07

#reports #MODV

[ModivCare](https://eninvs.com/all.php?name=MODV) (Health care provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181910)
(2025-03-06, After Market Close):

- Revenue 0% YoY (vs +2.2% in previous quarter and historical rate +12.5%)
- EBITDA -26.2% YoY (vs -13.2% in previous quarter and historical rate +1.8%)
- EBITDA margin 4.4% decreased compared to 6.0% same period last year
- Net Debt decreased by $24 mln over the past reporting period (48.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 152.1% of market cap
- EV/EBITDA multiple is 73x compared to historical level (75th percentile) of 43.5x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +1.3%

------------------------------------------------

2025-03-07

#reports #LOCO

[El Pollo Loco](https://eninvs.com/all.php?name=LOCO) (Restaurants) reported for 2024 q4
(2025-03-06, After Market Close):

- Revenue +1.8% YoY (vs 0.0% in previous quarter and historical rate +1.3%)
- EBITDA +18.2% YoY (vs -22.2% in previous quarter and historical rate -0.4%)
- EBITDA margin 11.4% increased compared to 9.8% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 5.4x compared to historical level (75th percentile) of 6.8x
- EV/Sales multiple is 0.7x

------------------------------------------------

2025-03-07

#reports #KVHI

[KVH Industries](https://eninvs.com/all.php?name=KVHI) (Communication Equipment) reported for 2024 q4
(2025-03-06, Before Market Open):

- Revenue -12.9% YoY (vs -14.7% in previous quarter and historical rate -12.6%)
- EBITDA margin -11.1% increased compared to -38.7% same period last year
- EV/EBITDA multiple is 4.6x compared to historical level (75th percentile) of 18.7x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -2.4% vs S&P500 -1.0%

------------------------------------------------

2025-03-07

#reports #KRO

[Kronos Worldwide](https://eninvs.com/all.php?name=KRO) (Specialty Chemicals) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181909)
(2025-03-05, After Market Close):

- Revenue +5.8% YoY (vs +22.2% in previous quarter and historical rate +2.7%)
- EBITDA +616.7% YoY (vs +5900.0% in previous quarter and historical rate +64.0%)
- EBITDA margin 10.2% increased compared to 1.5% same period last year
- Net Debt decreased by $54 mln over the past reporting period (5.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 13.1% of market cap
- EV/EBITDA multiple is 7.2x compared to historical level (75th percentile) of 23x
- EV/Sales multiple is 0.7x

------------------------------------------------

2025-03-07

#reports #III

[Information Services Group](https://eninvs.com/all.php?name=III) (Information Technology Services) reported for 2024 q4
(2025-03-06, After Market Close):

- Revenue -12.1% YoY (vs -15.3% in previous quarter and historical rate -3.0%)
- EBITDA margin 1.7% increased compared to -3.0% same period last year
- Net Debt decreased by $60 mln over the past reporting period (39.5% of market cap)
- EV/EBITDA multiple is 21.2x compared to historical level (75th percentile) of 14.6x
- EV/Sales multiple is 0.9x

------------------------------------------------

2025-03-07

#reports #HVT-A

[Haverty Furniture Companies](https://eninvs.com/all.php?name=HVT-A) (Home Improvement Retail) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181965):

- Revenue -12.8% YoY (vs -20.0% in previous quarter and historical rate -10.0%)
- EBITDA -33.3% YoY (vs -57.7% in previous quarter and historical rate -28.9%)
- EBITDA margin 7.6% decreased compared to 10.0% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0 bln (negative), 1.1% of market cap
- EV/EBITDA multiple is 10.8x compared to historical level (75th percentile) of 7.9x
- EV/Sales multiple is 0.6x

------------------------------------------------

2025-03-07

#reports #HDSN

[Hudson Technologies](https://eninvs.com/all.php?name=HDSN) (Specialty Chemicals) reported for 2024 q4
(2025-03-06, After Market Close):

- Revenue -22.2% YoY (vs -18.4% in previous quarter and historical rate +14.5%)
- EBITDA -160% YoY (vs -66.7% in previous quarter and historical rate +1.9%)
- EBITDA margin -8.6% decreased compared to 11.1% same period last year
- Net Debt decreased by $12 mln over the past reporting period (4.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 34.9% of market cap
- EV/EBITDA multiple is 5.8x compared to historical level (75th percentile) of 6.5x
- EV/Sales multiple is 0.8x

At the opening of the session the share price went down -0.1%

------------------------------------------------

2025-03-07

#reports #GWRS

[Global Water Resources](https://eninvs.com/all.php?name=GWRS) (Utilities — Regulated Water) reported for 2024 q4
(2025-03-05, After Market Close):

- Revenue +108.3% YoY (vs -6.7% in previous quarter and historical rate +17.8%)
- EBITDA -40% YoY (vs 0.0% in previous quarter and historical rate +19.9%)
- EBITDA margin 12.0% decreased compared to 41.7% same period last year
- Net Debt decreased by $4 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0 bln (negative), 6.7% of market cap
- EV/EBITDA multiple is 20.3x compared to historical level (75th percentile) of 20.5x
- EV/Sales multiple is 6.3x

At the opening of the session the share price went down -0.1% vs S&P500 -1.0%

------------------------------------------------

2025-03-07

#reports #GWRE

[Guidewire Software](https://eninvs.com/all.php?name=GWRE) (Software provider) reported for 2024 q4
(2025-03-06, After Market Close):

- Revenue +19.9% YoY (vs +27.1% in previous quarter and historical rate +26.7%)
- EBITDA margin 7.6% increased compared to -0.8% same period last year
- Net Debt decreased by $283 mln over the past reporting period (1.8% of market cap)
- EV/Sales multiple is 9.8x

------------------------------------------------

2025-03-07

#reports #FNKO

[Funko](https://eninvs.com/all.php?name=FNKO) (Vinyl figurine manufacturer) reported for 2024 q4
(2025-03-06, After Market Close):

- Revenue +1% YoY (vs -6.4% in previous quarter and historical rate +3.9%)
- EBITDA margin 23.5% increased compared to -16.5% same period last year
- Net Debt decreased by $50 mln over the past reporting period (9.2% of market cap)
- FCF (LTM) +$0 bln (positive), 5.7% of market cap
- EV/EBITDA multiple is 5.5x compared to historical level (75th percentile) of 37.5x
- EV/Sales multiple is 0.7x

------------------------------------------------

2025-03-07

#reports #FNA

[Paragon 28, Inc.](https://eninvs.com/all.php?name=FNA) (Medical Devices) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181907)
(2025-03-03, After Market Close):

- Revenue +18% YoY (vs +17.0% in previous quarter and historical rate +38.0%)
- EBITDA margin -5.6% increased compared to -9.8% same period last year
- Net Debt increased by $5 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 3.3% of market cap
- EV/Sales multiple is 4.5x

At the opening of the session the share price went neutrally vs S&P500 -0.3%

------------------------------------------------

2025-03-07

#reports #EVC

[Entravision Communications Corporation](https://eninvs.com/all.php?name=EVC) (Broadcasting) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181904)
(2025-03-06, After Market Close):

- Revenue -66.6% YoY (vs -64.6% in previous quarter and historical rate +2.4%)
- EBITDA margin -42.1% decreased compared to -2.8% same period last year
- Net Debt decreased by $52 mln over the past reporting period (27.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 30.5% of market cap
- EV/Sales multiple is 0.6x

------------------------------------------------

2025-03-07

#reports #DOMO

[Domo](https://eninvs.com/all.php?name=DOMO) (Software — Application) reported for 2024 q4
(2025-03-06, After Market Close):

- Revenue -1.3% YoY (vs 0.0% in previous quarter and historical rate +7.5%)
- EBITDA margin -7.6% increased compared to -8.8% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0 bln (negative), 7.6% of market cap
- EV/Sales multiple is 1x

------------------------------------------------

2025-03-07

#reports #DCTH

[Delcath Systems](https://eninvs.com/all.php?name=DCTH) (Medical Devices) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181902)
(2025-03-06, Before Market Open):

- Revenue +1400% YoY (vs +1000.0% in previous quarter and historical rate +62.5%)
- EBITDA margin 13.3% increased compared to -1200.0% same period last year
- Net Debt decreased by $54 mln over the past reporting period (14.2% of market cap)
- FCF (LTM) -$0 bln (negative), 6.3% of market cap
- EV/Sales multiple is 8.9x

At the opening of the session the share price went down -3.5% vs S&P500 -1.0%

------------------------------------------------

2025-03-07

#reports #COOK

[Traeger, Inc.](https://eninvs.com/all.php?name=COOK) (Furnishings, Fixtures and Appliances) reported for 2024 q4
(2025-03-06, After Market Close):

- Revenue +3.7% YoY (vs +3.4% in previous quarter and historical rate -6.4%)
- EBITDA margin 1.8% increased compared to -4.9% same period last year
- Net Debt decreased by $6 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) +$0 bln (positive), 1.4% of market cap
- EV/EBITDA multiple is 63.3x compared to historical level (75th percentile) of 803x
- EV/Sales multiple is 1.2x

------------------------------------------------

2025-03-07

#reports #BURL

[Burlington Stores](https://eninvs.com/all.php?name=BURL) (Clothes seller) reported for 2024 q4
(2025-03-06, Before Market Open):

- Revenue +4.8% YoY (vs +10.6% in previous quarter and historical rate +4.7%)
- EBITDA +8.6% YoY (vs +29.3% in previous quarter and historical rate +31.2%)
- EBITDA margin 13.5% increased compared to 13.0% same period last year
- Net Debt decreased by $5 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) -$0.2 bln (negative), 1.4% of market cap
- EV/EBITDA multiple is 20.5x compared to historical level (75th percentile) of 27.2x
- EV/Sales multiple is 2x

At the opening of the session the share price went up +13.4% vs S&P500 -1.0%

------------------------------------------------

2025-03-07

#reports #ANF

[Abercrombie & Fitch](https://eninvs.com/all.php?name=ANF) (Clothing and accessories stores chain ) reported for 2024 q4
(2025-03-05, Before Market Open):

- Revenue +9.1% YoY (vs +14.5% in previous quarter and historical rate +10.4%)
- EBITDA +13% YoY (vs +3.5% in previous quarter and historical rate +57.5%)
- EBITDA margin 18.1% increased compared to 17.5% same period last year
- Net Debt decreased by $197 mln over the past reporting period (4.6% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.5% of market cap
- EV/EBITDA multiple is 5.4x compared to historical level (75th percentile) of 10.3x
- EV/Sales multiple is 0.9x

At the opening of the session the share price went down -12.5% vs S&P500 -0.4%

------------------------------------------------

2025-03-07

#reports #AKA

[a.k.a. Brands Holding Corp.](https://eninvs.com/all.php?name=AKA) (Internet Retail) reported for 2024 q4
(2023-11-08, After Market Close):

- Revenue +6.7% YoY (vs +6.4% in previous quarter and historical rate -13.0%)
- EBITDA margin 3.1% increased compared to -0.7% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 176.9x compared to historical level (75th percentile) of 411.2x
- EV/Sales multiple is 4.6x

At the opening of the session the share price went down -9.9%

------------------------------------------------

2025-03-07

#reports #AGS

[PlayAGS](https://eninvs.com/all.php?name=AGS) (Gambling) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181944)
(2025-03-11, After Market Close):

- Revenue +9.6% YoY (vs +11.2% in previous quarter and historical rate +15.4%)
- EBITDA +10.8% YoY (vs +11.8% in previous quarter and historical rate +19.5%)
- EBITDA margin 39.8% increased compared to 39.4% same period last year
- Net Debt increased by $6 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) +$0 bln (positive), 2.9% of market cap
- EV/EBITDA multiple is 6.5x compared to historical level (75th percentile) of 7.2x
- EV/Sales multiple is 2.5x

------------------------------------------------

2025-03-07

#reports #ACU

[Acme United Corporation](https://eninvs.com/all.php?name=ACU) (Household and Personal Products) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181964)
(2025-02-28, Before Market Open):

- Revenue +9.5% YoY (vs -4.0% in previous quarter and historical rate +2.2%)
- EBITDA +18.2% YoY (vs 0.0% in previous quarter and historical rate +35.2%)
- EBITDA margin 7591.3% increased compared to 7033.3% same period last year
- Net Debt increased by $16.1 bln since the start of the year (12099.9% of market cap)
- FCF (LTM) +$10.4 bln (positive), 7817.6% of market cap
- EV/EBITDA multiple is 4.6x compared to historical level (75th percentile) of 9.3x
- EV/Sales multiple is 83.9x

------------------------------------------------

2025-03-06

#reports #VEEV

[Veeva Systems](https://eninvs.com/all.php?name=VEEV) (Software provider) reported for [2024 q4](https://eninvs.com/press_release.php?ticker=VEEV&q=2024 q4&id=709914)
(2025-03-05, After Market Close):

- Revenue +14.3% YoY (vs +13.3% in previous quarter and historical rate +13.6%)
- EBITDA +37.3% YoY (vs +39.6% in previous quarter and historical rate +17.1%)
- EBITDA margin 27.0% increased compared to 22.5% same period last year
- Net Debt decreased by $83 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$1 bln (positive), 2.9% of market cap
- EV/EBITDA multiple is 42.8x compared to historical level (75th percentile) of 63.7x
- EV/Sales multiple is 11.1x

------------------------------------------------

2025-03-06

#reports #TREE

[LendingTree](https://eninvs.com/all.php?name=TREE) (Banking service provider) reported for 2024 q4
(2025-03-05, After Market Close):

- Revenue +95.5% YoY (vs +68.4% in previous quarter and historical rate -0.5%)
- Net Income -38.5% YoY (vs -5900.0% in previous quarter and historical rate -12.8%)
- Net Income margin 3.1% decreased compared to 9.7% same period last year
- P/S multiple is 0.6x
- Price to book: 5.7x

------------------------------------------------

2025-03-06

#reports #SGHT

[Sight Sciences, Inc.](https://eninvs.com/all.php?name=SGHT) (Medical Devices) reported for 2024 q4
(2025-03-05, After Market Close):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +29.6%)
- EBITDA margin -131.6% decreased compared to -126.3% same period last year
- Net Debt increased by $3 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) -$0 bln (negative), 17.3% of market cap
- EV/Sales multiple is 0.4x

------------------------------------------------

2025-03-06

#reports #RSKD

[Riskified Ltd.](https://eninvs.com/all.php?name=RSKD) (Software — Application) reported for 2024 q4
(2025-03-05, Before Market Open):

- Revenue +11.9% YoY (vs +9.7% in previous quarter and historical rate +12.4%)
- Net Debt increased by $12 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 11.5% of market cap
- EV/Sales multiple is 1.4x

At the opening of the session the share price went down -8.0% vs S&P500 -0.4%

------------------------------------------------

2025-03-06

#reports #PKOH

[Park-Ohio](https://eninvs.com/all.php?name=PKOH) (Specialty Industrial Machinery) reported for 2024 q4
(2025-03-05, After Market Close):

- Revenue -0.3% YoY (vs -0.2% in previous quarter and historical rate +5.2%)
- EBITDA -11.5% YoY (vs -5.9% in previous quarter and historical rate +70.8%)
- EBITDA margin 5.9% decreased compared to 6.7% same period last year
- Net Debt decreased by $33 mln over the past reporting period (12.0% of market cap)
- FCF (LTM) -$0 bln (negative), 4.0% of market cap
- EV/EBITDA multiple is 7.5x compared to historical level (75th percentile) of 13.4x
- EV/Sales multiple is 0.5x

------------------------------------------------

2025-03-06

#reports #NINE

[Nine Energy Service](https://eninvs.com/all.php?name=NINE) (Oil and Gas Equipment and Services) reported for 2024 q4
(2025-03-06, After Market Close):

- Revenue -2.1% YoY (vs -2.1% in previous quarter and historical rate +22.4%)
- EBITDA +46.7% YoY (vs -30.8% in previous quarter and historical rate +59.8%)
- EBITDA margin 15.6% increased compared to 10.4% same period last year
- Net Debt decreased by $10 mln over the past reporting period (25.0% of market cap)
- FCF (LTM) -$0 bln (negative), 15.0% of market cap
- EV/EBITDA multiple is 6.3x compared to historical level (75th percentile) of 11.3x
- EV/Sales multiple is 0.7x

------------------------------------------------

2025-03-06

#reports #MRVL

[Marvell Technology](https://eninvs.com/all.php?name=MRVL) (Integrated circuit manufacturer) reported for 2024 q4
(2025-03-05, After Market Close):

- Revenue +27.4% YoY (vs +6.8% in previous quarter and historical rate +11.4%)
- EBITDA +685% YoY (vs -62700.0% in previous quarter and historical rate -16.0%)
- EBITDA margin 17.3% increased compared to 2.8% same period last year
- Net Debt decreased by $111 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.4 bln (positive), 0.5% of market cap
- EV/Sales multiple is 13.8x

------------------------------------------------

2025-03-06

#reports #MG

[Mistras Group](https://eninvs.com/all.php?name=MG) (Security and Protection Services) reported for 2024 q4
(2025-03-05, After Market Close):

- Revenue -4.9% YoY (vs +2.2% in previous quarter and historical rate +2.6%)
- EBITDA +142.9% YoY (vs +2400.0% in previous quarter and historical rate +35.4%)
- EBITDA margin 9.8% increased compared to 3.8% same period last year
- Net Debt increased by $172 mln over the past reporting period (60.4% of market cap)
- FCF (LTM) -$0 bln (negative), 3.2% of market cap
- EV/EBITDA multiple is 6.4x compared to historical level (75th percentile) of 17.9x
- EV/Sales multiple is 0.6x

------------------------------------------------

2025-03-06

#reports #LPSN

[LivePerson](https://eninvs.com/all.php?name=LPSN) (Software provider) reported for 2024 q4
(2025-03-05, After Market Close):

- Revenue -23.2% YoY (vs -26.7% in previous quarter and historical rate -8.3%)
- EBITDA margin -80.8% decreased compared to -43.2% same period last year
- Net Debt decreased by $511 mln over the past reporting period (523.7% of market cap)
- FCF (LTM) -$0.5 bln (negative), 472.4% of market cap
- EV/EBITDA multiple is 0.6x compared to historical level (75th percentile) of 0.6x
- EV/Sales multiple is -0.3x

------------------------------------------------

2025-03-06

#reports #INVE

[Identiv](https://eninvs.com/all.php?name=INVE) (Computer Hardware) reported for 2024 q4
(2025-03-05, After Market Close):

- Revenue -75.9% YoY (vs -78.1% in previous quarter and historical rate -16.2%)
- EBITDA margin -57.1% decreased compared to -3.4% same period last year
- Net Debt increased by $9 mln over the past reporting period (11.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 154.2% of market cap
- EV/EBITDA multiple is 2.4x compared to historical level (75th percentile) of 90.5x
- EV/Sales multiple is -1.2x

------------------------------------------------

2025-03-06

#reports #HYFM

[Hydrofarm Holdings Group, Inc.](https://eninvs.com/all.php?name=HYFM) (Farm and Heavy Construction Machinery) reported for 2024 q4
(2025-02-26, Before Market Open):

- Revenue -21.3% YoY (vs -18.5% in previous quarter and historical rate -25.6%)
- EBITDA -25% YoY (vs +100.0% in previous quarter and historical rate +25.7%)
- EBITDA margin 32.4% decreased compared to 34.0% same period last year
- Net Debt decreased by $5 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) +$0 bln (positive), 3.6% of market cap
- EV/EBITDA multiple is 77.3x compared to historical level (75th percentile) of 172x
- EV/Sales multiple is 1.6x

At the opening of the session the share price went up +1.5% vs S&P500 +0.2%

------------------------------------------------

2025-03-06

#reports #EYPT

[EyePoint Pharmaceuticals](https://eninvs.com/all.php?name=EYPT) (Biotechnology) reported for 2024 q4
(2025-03-05, Before Market Open):

- Revenue -14.3% YoY (vs -26.7% in previous quarter and historical rate +9.6%)
- EBITDA margin -375.0% decreased compared to -114.3% same period last year
- Net Debt decreased by $117 mln over the past reporting period (32.7% of market cap)
- FCF (LTM) -$0 bln (negative), 12.3% of market cap
- EV/Sales multiple is 0.2x

At the opening of the session the share price went up +4.1% vs S&P500 -0.4%

------------------------------------------------

2025-03-06

#reports #DIN

[Dine Brands Global](https://eninvs.com/all.php?name=DIN) (Restaurants) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181834)
(2025-03-05, Before Market Open):

- Revenue -0.5% YoY (vs -3.9% in previous quarter and historical rate -3.0%)
- EBITDA -3.9% YoY (vs +1225.0% in previous quarter and historical rate +30.6%)
- EBITDA margin 71.7% decreased compared to 74.3% same period last year
- Net Debt increased by $112 mln over the past reporting period (31.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 19.4% of market cap
- EV/EBITDA multiple is 3.5x compared to historical level (75th percentile) of 10.1x
- EV/Sales multiple is 2.3x

At the opening of the session the share price went down -2.5% vs S&P500 -0.4%

------------------------------------------------

2025-03-06

#reports #CCRN

[Cross Country Healthcare](https://eninvs.com/all.php?name=CCRN) (Medical Care Facilities) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181832)
(2025-03-03, After Market Close):

- Revenue -25.1% YoY (vs -28.7% in previous quarter and historical rate +7.5%)
- EBITDA -94.4% YoY (vs -72.0% in previous quarter and historical rate -10.5%)
- EBITDA margin 0.3% decreased compared to 4.3% same period last year
- Net Debt increased by $60 mln over the past reporting period (10.8% of market cap)
- FCF (LTM) +$0 bln (positive), 8.6% of market cap
- EV/Sales multiple is 0.4x

At the opening of the session the share price went down -0.2% vs S&P500 -0.3%

------------------------------------------------

2025-03-06

#reports #AWRE

[Aware](https://eninvs.com/all.php?name=AWRE) (Software — Application) reported for 2024 q4
(2025-03-05, After Market Close):

- Revenue +25% YoY (vs -33.3% in previous quarter and historical rate +10.1%)
- EBITDA margin -20.0% increased compared to -100.0% same period last year
- Net Debt decreased by $1 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) -$0 bln (negative), 9.2% of market cap
- EV/Sales multiple is 0.5x

------------------------------------------------

2025-03-06

#reports #ALTO

[Alto Ingredients](https://eninvs.com/all.php?name=ALTO) (Specialty Chemicals) reported for 2024 q4
(2025-03-05, After Market Close):

- Revenue -13.9% YoY (vs -20.8% in previous quarter and historical rate -4.9%)
- EBITDA margin -13.6% decreased compared to -3.6% same period last year
- Net Debt increased by $4 mln over the past reporting period (3.7% of market cap)
- FCF (LTM) +$0 bln (positive), 11.1% of market cap
- EV/Sales multiple is 0.2x

------------------------------------------------

2025-03-06

#reports #ADES

[Advanced Emissions Solutions](https://eninvs.com/all.php?name=ADES) (Pollution and Treatment Controls) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181858)
(2023-11-08, After Market Close):

- Revenue +275% YoY (vs +16.7% in previous quarter and historical rate +21.5%)
- EBITDA -83.3% YoY (vs +100.0% in previous quarter)
- EBITDA margin 1.0% decreased compared to 21.4% same period last year
- Net Debt increased by $40 mln over the past reporting period (33.0% of market cap)
- FCF (LTM) +$0 bln (positive), 4.9% of market cap
- EV/EBITDA multiple is 44.1x compared to historical level (75th percentile) of 6.9x
- EV/Sales multiple is 0.7x

At the opening of the session the share price went up +0.5%

------------------------------------------------

2025-03-06

#reports #MDB
@ saas

[MongoDB](https://eninvs.com/all.php?name=MDB) (Database developer) reported for 2024 q4
(2025-03-05, After Market Close):

- Revenue +19.7% YoY (vs +22.2% in previous quarter and historical rate +32.9%)
- EBITDA margin -2.9% increased compared to -14.2% same period last year
- Net Debt decreased by $1.2 bln since the start of the year (6.5% of market cap)
- FCF (LTM) +$1.5 bln (positive), 8.2% of market cap
- EV/Sales multiple is 7.8x

------------------------------------------------

2025-03-06

#reports #ZS
@ cybersecurity , @ saas

[Zscaler](https://eninvs.com/all.php?name=ZS) (Internet security platform) reported for 2024 q4
(2025-03-05, After Market Close):

- Revenue +23.4% YoY (vs +26.4% in previous quarter and historical rate +42.2%)
- EBITDA margin 3.7% increased compared to 0.2% same period last year
- Net Debt decreased by $171 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 0.8% of market cap
- EV/EBITDA multiple is 214.5x compared to historical level (75th percentile) of 8138.3x
- EV/Sales multiple is 11.5x

------------------------------------------------

2025-03-05

#reports #YMAB

[Y-mAbs Therapeutics](https://eninvs.com/all.php?name=YMAB) (Therapeutic drug developer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181798)
(2025-03-04, Before Market Open):

- Revenue +13% YoY (vs -10.0% in previous quarter and historical rate +48.0%)
- EBITDA margin -23.1% decreased compared to -13.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 4.5% of market cap
- EV/Sales multiple is 1.8x

At the opening of the session the share price went down -15.6% vs S&P500 -0.3%

------------------------------------------------

2025-03-05

#reports #WEYS

[Weyco Group](https://eninvs.com/all.php?name=WEYS) (Footwear and Accessories) reported for 2024 q4
(2025-03-11, After Market Close):

- Revenue -1.2% YoY (vs -11.9% in previous quarter and historical rate +7.1%)
- EBITDA 0% YoY (vs -15.4% in previous quarter and historical rate +17.9%)
- EBITDA margin 15.0% increased compared to 14.8% same period last year
- Net Debt increased by $3 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0 bln (positive), 2.5% of market cap
- EV/EBITDA multiple is 6.5x compared to historical level (75th percentile) of 6.8x
- EV/Sales multiple is 0.9x

------------------------------------------------

2025-03-05

#reports #TGT

[Target](https://eninvs.com/all.php?name=TGT) (Shop owner) reported for 2024 q4
(2025-03-04, Before Market Open):

- Revenue -3.1% YoY (vs +1.1% in previous quarter and historical rate +0.2%)
- EBITDA -21.4% YoY (vs +180.6% in previous quarter and historical rate +21.6%)
- EBITDA margin 6.5% decreased compared to 8.0% same period last year
- Net Debt decreased by $1.2 bln since the start of the year (2.2% of market cap)
- FCF (LTM) -$0.7 bln (negative), 1.3% of market cap
- EV/EBITDA multiple is 8.3x compared to historical level (75th percentile) of 13.4x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -2.7% vs S&P500 -0.3%

------------------------------------------------

2025-03-05

#reports #STIM

[Neuronetics](https://eninvs.com/all.php?name=STIM) (Diagnostics and Research) reported for 2024 q4
(2025-03-04, Before Market Open):

- Revenue +10% YoY (vs +5.6% in previous quarter and historical rate +10.5%)
- EBITDA margin -50.0% decreased compared to -20.0% same period last year
- Net Debt increased by $1.6 bln since the start of the year (1032.3% of market cap)
- FCF (LTM) -$0 bln (negative), 15.7% of market cap
- EV/Sales multiple is 23.8x

At the opening of the session the share price went up +2.1% vs S&P500 -0.3%

------------------------------------------------

2025-03-05

#reports #SND

[Smart Sand](https://eninvs.com/all.php?name=SND) (Oil and Gas Equipment and Services) reported for 2024 q4
(2025-03-03, After Market Close):

- Revenue +46.8% YoY (vs -18.2% in previous quarter and historical rate +44.3%)
- EBITDA margin 4.4% increased compared to -11.3% same period last year
- Net Debt increased by $36 mln over the past reporting period (44.7% of market cap)
- EV/EBITDA multiple is 23.3x compared to historical level (75th percentile) of 21.8x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +3.3% vs S&P500 -0.3%

------------------------------------------------

2025-03-05

#reports #ROST

[Ross Stores](https://eninvs.com/all.php?name=ROST) (Clothing and accessories seller) reported for 2024 q4
(2025-03-04, After Market Close):

- Revenue -1.8% YoY (vs +3.0% in previous quarter and historical rate +3.8%)
- EBITDA -1.7% YoY (vs +9.6% in previous quarter and historical rate +11.4%)
- EBITDA margin 14.3% has not changed compared to 14.3% same period last year
- EV/EBITDA multiple is 14.7x compared to historical level (75th percentile) of 18.2x
- EV/Sales multiple is 2.1x

------------------------------------------------

2025-03-05

#reports #RIGL

[Rigel Pharmaceuticals](https://eninvs.com/all.php?name=RIGL) (Biotechnology) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181799)
(2024-08-06):

- Revenue +61.1% YoY (vs +96.4% in previous quarter and historical rate +28.5%)
- EBITDA +750% YoY (vs +1400.0% in previous quarter and historical rate +53.2%)
- EBITDA margin 29.3% increased compared to 5.6% same period last year
- Net Debt decreased by $24 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0 bln (negative), 0.1% of market cap
- EV/EBITDA multiple is 147.8x compared to historical level (75th percentile) of 367.2x
- EV/Sales multiple is 21.4x

------------------------------------------------

2025-03-05

#reports #PMTS

[CPI Card Group](https://eninvs.com/all.php?name=PMTS) (Credit Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181796)
(2025-03-04, Before Market Open):

- Revenue +21.4% YoY (vs +17.9% in previous quarter and historical rate +11.0%)
- Net Income +133.3% YoY (vs -75.0% in previous quarter and historical rate +32.4%)
- Net Income margin 5.6% increased compared to 2.9% same period last year
- P/E multiple is 9.2x compared to historical level (75th percentile) of 10.5x
- P/S multiple is 0.7x
- Price to book: -7.7x

At the opening of the session the share price went up +1.1% vs S&P500 -0.3%

------------------------------------------------

2025-03-05

#reports #OOMA

[Ooma](https://eninvs.com/all.php?name=OOMA) (Telecom Services) reported for [2024 q4](https://eninvs.com/press_release.php?ticker=OOMA&q=2024 q4&id=761737)
(2025-03-04, After Market Close):

- Revenue +4.8% YoY (vs +8.3% in previous quarter and historical rate +10.1%)
- EBITDA margin 1.5% increased compared to -1.6% same period last year
- Net Debt decreased by $4 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0 bln (positive), 6.2% of market cap
- EV/Sales multiple is 1.4x

------------------------------------------------

2025-03-05

#reports #OLPX

[Olaplex Holdings, Inc.](https://eninvs.com/all.php?name=OLPX) (Specialty Retail) reported for 2024 q4
(2025-03-04, Before Market Open):

- Revenue -9.8% YoY (vs -4.0% in previous quarter and historical rate -17.5%)
- EBITDA -73.7% YoY (vs -20.5% in previous quarter and historical rate -46.6%)
- EBITDA margin 5.0% decreased compared to 17.0% same period last year
- Net Debt decreased by $49 mln over the past reporting period (4.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 6.8% of market cap
- EV/EBITDA multiple is 15.3x compared to historical level (75th percentile) of 13.3x
- EV/Sales multiple is 2.8x

At the opening of the session the share price went up +8.4% vs S&P500 -0.3%

------------------------------------------------

2025-03-05

#reports #NVRO

[Nevro](https://eninvs.com/all.php?name=NVRO) (Medical equipment manufacturer) reported for 2024 q4
(2025-03-04, After Market Close):

- Revenue -8.6% YoY (vs -6.7% in previous quarter and historical rate +2.1%)
- EBITDA margin -46.2% decreased compared to -7.8% same period last year
- Net Debt decreased by $13 mln over the past reporting period (6.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 24.1% of market cap
- EV/Sales multiple is 0.4x

------------------------------------------------

2025-03-05

#reports #NPCE

[NeuroPace, Inc.](https://eninvs.com/all.php?name=NPCE) (Medical Devices) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181793)
(2025-03-04, After Market Close):

- Revenue +300% YoY (vs +31.3% in previous quarter and historical rate +38.2%)
- EBITDA margin -30.6% decreased compared to -27.8% same period last year
- Net Debt increased by $4 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0 bln (negative), 3.7% of market cap
- EV/Sales multiple is 2.4x

At the opening of the session the share price went down -0.1%

------------------------------------------------

2025-03-05

#reports #MFIN

[Medallion Financial](https://eninvs.com/all.php?name=MFIN) (Credit Services) reported for [2024 q4](https://eninvs.com/press_release.php?ticker=MFIN&q=2024 q4&id=820261)
(2025-01-30, After Market Close):

- Revenue +6.1% YoY (vs +8.2% in previous quarter and historical rate +11.4%)
- Net Income -25% YoY (vs -23.1% in previous quarter and historical rate -1.9%)
- Net Income margin 23.1% decreased compared to 32.7% same period last year
- P/E multiple is 4.3x compared to historical level (75th percentile) of 3.2x
- P/S multiple is 0.9x
- Price to book: 0.5x

At the opening of the session the share price went down -1.6% vs S&P500 +0.3%

------------------------------------------------

2025-03-05

#reports #MEC

[Mayville Engineering Company](https://eninvs.com/all.php?name=MEC) (Metal Fabrication) reported for 2024 q4
(2025-03-04, After Market Close):

- Revenue -18.8% YoY (vs -14.6% in previous quarter and historical rate +9.1%)
- EBITDA +120% YoY (vs -6.3% in previous quarter and historical rate +43.4%)
- EBITDA margin 27.3% increased compared to 10.1% same period last year
- Net Debt decreased by $31 mln over the past reporting period (10.9% of market cap)
- FCF (LTM) +$0 bln (positive), 13.7% of market cap
- EV/EBITDA multiple is 4.8x compared to historical level (75th percentile) of 9.2x
- EV/Sales multiple is 0.7x

------------------------------------------------

2025-03-05

#reports #KIDS

[OrthoPediatrics](https://eninvs.com/all.php?name=KIDS) (Medical equipment developer) reported for 2024 q4
(2025-03-04, After Market Close):

- Revenue +39.5% YoY (vs +37.5% in previous quarter and historical rate +28.6%)
- EBITDA margin -18.9% decreased compared to -7.9% same period last year
- Net Debt increased by $55 mln over the past reporting period (10.6% of market cap)
- FCF (LTM) -$0 bln (negative), 3.6% of market cap
- EV/Sales multiple is 2.5x

------------------------------------------------

2025-03-05

#reports #JWN

[Nordstrom](https://eninvs.com/all.php?name=JWN) (Clothes seller and shoes) reported for 2024 q4
(2025-03-04, After Market Close):

- Revenue -2.2% YoY (vs +4.3% in previous quarter and historical rate +1.0%)
- EBITDA +86.5% YoY (vs +61.1% in previous quarter and historical rate +18.6%)
- EBITDA margin 16.0% increased compared to 8.4% same period last year
- Net Debt decreased by $416 mln over the past reporting period (10.7% of market cap)
- FCF (LTM) -$0.4 bln (negative), 9.3% of market cap
- EV/EBITDA multiple is 4.7x compared to historical level (75th percentile) of 8.5x
- EV/Sales multiple is 0.5x

------------------------------------------------

2025-03-05

#reports #FTEK

[Fuel Tech](https://eninvs.com/all.php?name=FTEK) (Pollution and Treatment Controls) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181791)
(2025-03-04, After Market Close):

- Revenue -16.7% YoY (vs 0.0% in previous quarter and historical rate +3.1%)
- EBITDA margin -40.0% decreased compared to -16.7% same period last year
- Net Debt increased by $2 mln over the past reporting period (6.7% of market cap)
- FCF (LTM) -$0 bln (negative), 30.2% of market cap
- EV/Sales multiple is 0.5x

------------------------------------------------

2025-03-05

#reports #ESPR

[Esperion Therapeutics](https://eninvs.com/all.php?name=ESPR) (Medical device manufacturer) reported for 2024 q4
(2025-03-04, Before Market Open):

- Revenue +115.6% YoY (vs +52.9% in previous quarter and historical rate +75.8%)
- EBITDA margin -1.4% increased compared to -121.9% same period last year
- Net Debt decreased by $118 mln over the past reporting period (34.2% of market cap)
- EV/EBITDA multiple is 8x compared to historical level (75th percentile) of 38.8x
- EV/Sales multiple is 1.4x

At the opening of the session the share price went up +4.4% vs S&P500 -0.3%

------------------------------------------------

2025-03-05

#reports #EOLS

[Evolus](https://eninvs.com/all.php?name=EOLS) (Drug Manufacturers — Specialty and Generic) reported for 2024 q4
(2025-03-04, After Market Close):

- Revenue +29.5% YoY (vs +22.0% in previous quarter and historical rate +45.6%)
- EBITDA margin -2.5% increased compared to -11.5% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 2.4% of market cap
- EV/Sales multiple is 3.5x

------------------------------------------------

2025-03-05

#reports #CYRX

[CryoPort](https://eninvs.com/all.php?name=CYRX) (Logistic services provider) reported for 2024 q4
(2025-03-04, After Market Close):

- Revenue +5.3% YoY (vs +1.8% in previous quarter and historical rate +1.6%)
- EBITDA margin -435.0% increased compared to -556.1% same period last year
- Net Debt decreased by $4 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0 bln (negative), 13.6% of market cap
- EV/Sales multiple is 1x

------------------------------------------------

2025-03-05

#reports #CXDO

[Crexendo](https://eninvs.com/all.php?name=CXDO) (Telecom Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181789)
(2025-03-04, After Market Close):

- Revenue +14.3% YoY (vs +14.3% in previous quarter and historical rate +40.8%)
- EBITDA margin 6.3% decreased compared to 7.1% same period last year
- Net Debt decreased by $3 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) +$0 bln (positive), 3.2% of market cap
- EV/EBITDA multiple is 34.7x compared to historical level (75th percentile) of 76x
- EV/Sales multiple is 2.3x

------------------------------------------------

2025-03-05

#reports #CRCT

[Cricut, Inc.](https://eninvs.com/all.php?name=CRCT) (Computer Hardware) reported for 2024 q4
(2025-03-04, After Market Close):

- Revenue -9.5% YoY (vs -4.0% in previous quarter and historical rate -17.0%)
- EBITDA -18.2% YoY (vs -44.8% in previous quarter and historical rate -12.4%)
- EBITDA margin 8.6% decreased compared to 9.5% same period last year
- Net Debt decreased by $86 mln over the past reporting period (7.7% of market cap)
- FCF (LTM) +$0 bln (positive), 1.4% of market cap
- EV/EBITDA multiple is 8.2x compared to historical level (75th percentile) of 16.4x
- EV/Sales multiple is 1.1x

At the opening of the session the share price went up +0.4%

------------------------------------------------

2025-03-05

#reports #CDXC

[ChromaDex Corporation](https://eninvs.com/all.php?name=CDXC) (Biotechnology) reported for 2024 q4
(2025-03-04, After Market Close):

- Revenue +38.1% YoY (vs +36.8% in previous quarter and historical rate +16.2%)
- EBITDA margin 24.1% increased compared to 0.0% same period last year
- EV/EBITDA multiple is 47.6x compared to historical level (75th percentile) of 242.5x
- EV/Sales multiple is 4.3x

------------------------------------------------

2025-03-05

#reports #BOX

[Box](https://eninvs.com/all.php?name=BOX) (Cloud management platform provider ) reported for 2024 q4
(2025-03-04, After Market Close):

- Revenue +6.5% YoY (vs +5.3% in previous quarter and historical rate +7.8%)
- EBITDA -16.2% YoY (vs +32.4% in previous quarter and historical rate +56.6%)
- EBITDA margin 11.1% decreased compared to 14.1% same period last year
- Net Debt increased by $257 mln over the past reporting period (5.4% of market cap)
- FCF (LTM) -$0.4 bln (negative), 8.7% of market cap
- EV/EBITDA multiple is 44.9x compared to historical level (75th percentile) of 57.1x
- EV/Sales multiple is 6.4x

------------------------------------------------

2025-03-05

#reports #AOMR

[Angel Oak Mortgage, Inc.](https://eninvs.com/all.php?name=AOMR) (REIT — Mortgage) reported for 2024 q4
(2025-03-04, Before Market Open):

- Revenue +25% YoY (vs +28.6% in previous quarter and historical rate +33.1%)
- EBITDA 0% YoY (vs -7800.0% in previous quarter and historical rate -30.6%)
- EBITDA margin 40.0% decreased compared to 50.0% same period last year
- Net Debt decreased by $203 mln over the past reporting period (86.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 38.2% of market cap
- EV/Sales multiple is 10.1x

At the opening of the session the share price went up +0.2% vs S&P500 -0.3%

------------------------------------------------

2025-03-05

#reports #SE
@ gaming

[Sea](https://eninvs.com/all.php?name=SE) (Electronic Gaming and Multimedia) reported for 2024 q4
(2025-03-04, Before Market Open):

- Revenue +36.9% YoY (vs +30.8% in previous quarter and historical rate +20.9%)
- EBITDA margin 5.8% increased compared to -2.0% same period last year
- Net Debt decreased by $1 bln since the start of the year (1.3% of market cap)
- FCF (LTM) +$2.5 bln (positive), 3.3% of market cap
- EV/EBITDA multiple is 88.6x compared to historical level (75th percentile) of 145.6x
- EV/Sales multiple is 4.1x

At the opening of the session the share price went up +5.7% vs S&P500 -0.3%

------------------------------------------------

2025-03-04

#reports #TDUP

[ThredUp Inc.](https://eninvs.com/all.php?name=TDUP) (Internet Retail) reported for 2024 q4
(2025-03-03, After Market Close):

- Revenue -17.3% YoY (vs -11.0% in previous quarter and historical rate +23.9%)
- EBITDA margin -3.0% increased compared to -12.3% same period last year
- Net Debt decreased by $5 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) -$0 bln (negative), 1.4% of market cap
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +0.7%

------------------------------------------------

2025-03-04

#reports #SENS

[Senseonics](https://eninvs.com/all.php?name=SENS) (Diagnostics and Research) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181696)
(2025-03-03, After Market Close):

- Revenue 0% YoY (vs -33.3% in previous quarter and historical rate +20.4%)
- EBITDA -170% YoY (vs -2400.0% in previous quarter and historical rate -26.9%)
- EBITDA margin -175.0% decreased compared to 250.0% same period last year
- Net Debt increased by $7 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0 bln (negative), 5.9% of market cap
- EV/Sales multiple is 25.6x

------------------------------------------------

2025-03-04

#reports #OCUL

[Ocular Therapeutix](https://eninvs.com/all.php?name=OCUL) (Biotechnology) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181692)
(2025-03-03, Before Market Open):

- Revenue +13.3% YoY (vs 0.0% in previous quarter and historical rate +16.2%)
- EBITDA margin -294.1% decreased compared to -126.7% same period last year
- Net Debt increased by $35 mln over the past reporting period (3.5% of market cap)
- FCF (LTM) +$0.3 bln (positive), 25.9% of market cap
- EV/Sales multiple is 10.9x

At the opening of the session the share price went down -2.8% vs S&P500 +0.9%

------------------------------------------------

2025-03-04

#reports #JRVR

[James River](https://eninvs.com/all.php?name=JRVR) (Insurance — Specialty) reported for 2024 q4
(2025-03-03, After Market Close):

- Revenue -41.7% YoY (vs -18.0% in previous quarter and historical rate -1.4%)
- Net Income -415% YoY (vs -290.0% in previous quarter and historical rate +34.2%)
- Net Income margin -49.6% decreased compared to 9.2% same period last year
- P/S multiple is 0.3x
- Price to book: 0.4x

------------------------------------------------

2025-03-04

#reports #HSII

[Heidrick & Struggles International](https://eninvs.com/all.php?name=HSII) (Executive recruitment specialist) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181689)
(2025-03-03, After Market Close):

- Revenue +334.2% YoY (vs +5.6% in previous quarter and historical rate +20.8%)
- EBITDA -51.9% YoY (vs -11.1% in previous quarter and historical rate -19.9%)
- EBITDA margin 1.2% decreased compared to 10.5% same period last year
- Net Debt increased by $306 mln over the past reporting period (37.9% of market cap)
- FCF (LTM) -$0.1 bln (negative), 8.9% of market cap
- EV/EBITDA multiple is 9.3x compared to historical level (75th percentile) of 5.9x
- EV/Sales multiple is 0.3x

------------------------------------------------

2025-03-04

#reports #ENFN

[Enfusion, Inc.](https://eninvs.com/all.php?name=ENFN) (Software — Application) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181763)
(2025-03-03, After Market Close):

- Revenue +15.2% YoY (vs +15.9% in previous quarter and historical rate +18.7%)
- EBITDA -16.7% YoY (vs +20.0% in previous quarter)
- EBITDA margin 9.4% decreased compared to 13.0% same period last year
- Net Debt decreased by $6 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.8% of market cap
- EV/EBITDA multiple is 54.4x compared to historical level (75th percentile) of 51.1x
- EV/Sales multiple is 5.1x

At the opening of the session the share price went up +0.1%

------------------------------------------------

2025-03-04

#reports #EBS

[Emergent BioSolutions](https://eninvs.com/all.php?name=EBS) (Medicines developer) reported for 2024 q4
(2025-03-03, After Market Close):

- Revenue -29.3% YoY (vs +8.9% in previous quarter and historical rate -8.8%)
- EBITDA margin 22.1% increased compared to -4.3% same period last year
- Net Debt decreased by $513 mln over the past reporting period (149.5% of market cap)
- FCF (LTM) +$0.2 bln (positive), 68.5% of market cap
- EV/EBITDA multiple is 856.2x compared to historical level (75th percentile) of 5.4x
- EV/Sales multiple is 0.8x

------------------------------------------------

2025-03-04

#reports #CRD-B

[Crawford & Company](https://eninvs.com/all.php?name=CRD-B) (Insurance Brokers) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181766):

- Revenue +11.5% YoY (vs +1.5% in previous quarter and historical rate +0.2%)
- Net Income margin 1.7% increased compared to -0.3% same period last year
- P/E multiple is 22.5x compared to historical level (75th percentile) of 28.1x
- P/S multiple is 0.5x
- Price to book: 3.8x

------------------------------------------------

2025-03-04

#reports #BLFS

[BioLife Solutions](https://eninvs.com/all.php?name=BLFS) (Medical Instruments and Supplies) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181683)
(2025-03-03, Before Market Open):

- Revenue +257.7% YoY (vs -14.8% in previous quarter and historical rate +17.4%)
- EBITDA margin -48.4% decreased compared to -34.6% same period last year
- Net Debt increased by $4 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0 bln (negative), 4.5% of market cap
- EV/Sales multiple is 6.4x

At the opening of the session the share price went up +7.5% vs S&P500 +0.9%

------------------------------------------------

2025-03-04

#reports #BDSX

[Biodesix](https://eninvs.com/all.php?name=BDSX) (Diagnostics and Research) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181682)
(2025-03-03, After Market Close):

- Revenue +33.3% YoY (vs +38.5% in previous quarter and historical rate +16.1%)
- EBITDA margin -35.0% increased compared to -46.7% same period last year
- Net Debt increased by $5 mln over the past reporting period (4.8% of market cap)
- FCF (LTM) +$0 bln (positive), 2.9% of market cap
- EV/Sales multiple is 2x

------------------------------------------------

2025-03-04

#reports #ATSG

[Air Transport Services](https://eninvs.com/all.php?name=ATSG) (Air freight and aircraft leasing) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=8&id=82169)
(2025-03-03, After Market Close):

- Revenue +279.5% YoY (vs -9.9% in previous quarter and historical rate +21.6%)
- EBITDA +90.5% YoY (vs -1.5% in previous quarter and historical rate +0.5%)
- EBITDA margin 12.2% decreased compared to 24.4% same period last year
- Net Debt decreased by $38 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 12.7% of market cap
- EV/EBITDA multiple is 4.8x compared to historical level (75th percentile) of 5.4x
- EV/Sales multiple is 0.9x

------------------------------------------------

2025-03-04

#reports #ADTN

[ADTRAN](https://eninvs.com/all.php?name=ADTN) (Communication Equipment) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181783)
(2025-02-26, After Market Close):

- Revenue +8% YoY (vs -16.2% in previous quarter and historical rate +32.8%)
- EBITDA margin 2.9% increased compared to -7.1% same period last year
- Net Debt increased by $12 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0 bln (positive), 5.0% of market cap
- EV/Sales multiple is 1.5x

At the opening of the session the share price went up +15.8% vs S&P500 +0.3%

------------------------------------------------

2025-03-04

#reports #PLUG
@ renewable-energy

[Plug Power](https://eninvs.com/all.php?name=PLUG) (Handling equipment manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181693)
(2025-03-03, Before Market Open):

- Revenue -14% YoY (vs -12.6% in previous quarter and historical rate +16.4%)
- EBITDA margin -680.6% decreased compared to -474.3% same period last year
- Net Debt increased by $126 mln over the past reporting period (9.8% of market cap)
- FCF (LTM) -$0 bln (negative), 0.6% of market cap
- EV/Sales multiple is 3x

------------------------------------------------

2025-03-04

#reports #NOVA
@ renewable-energy

[Sunnova Energy International](https://eninvs.com/all.php?name=NOVA) (Solar) reported for 2024 q4
(2025-03-03, Before Market Open):

- Revenue +211.9% YoY (vs +18.7% in previous quarter and historical rate +78.1%)
- EBITDA margin -10.7% increased compared to -26.3% same period last year
- Net Debt increased by $174 mln over the past reporting period (234.8% of market cap)
- FCF (LTM) -$1 bln (negative), 1384.6% of market cap
- EV/Sales multiple is 7.5x

At the opening of the session the share price went down -62.9% vs S&P500 +0.9%

------------------------------------------------

2025-03-01

#reports #VRTS

[Virtus Investment Partners](https://eninvs.com/all.php?name=VRTS) (Investment management service provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181657)
(2025-01-31, Before Market Open):

- Revenue +8.4% YoY (vs +3.7% in previous quarter and historical rate -4.5%)
- Net Income +2.6% YoY (vs +28.9% in previous quarter and historical rate +9.0%)
- Net Income margin 16.7% decreased compared to 17.7% same period last year
- P/E multiple is 9.1x compared to historical level (75th percentile) of 12.4x
- P/S multiple is 1.5x
- Price to book: 1.6x

At the opening of the session the share price went down -1.8% vs S&P500 +0.3%

------------------------------------------------

2025-03-01

#reports #SPR

[Spirit AeroSystems](https://eninvs.com/all.php?name=SPR) (Commercial aircraft structures manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181556)
(2025-02-24, After Market Close):

- Revenue -8.9% YoY (vs +2.2% in previous quarter and historical rate +17.6%)
- EBITDA -308.3% YoY (vs -514.3% in previous quarter and historical rate -37.4%)
- EBITDA margin -34.9% decreased compared to 15.3% same period last year
- Net Debt decreased by $4.4 bln since the start of the year (113.8% of market cap)
- FCF (LTM) -$0.9 bln (negative), 23.9% of market cap
- EV/Sales multiple is 1.3x

At the opening of the session the share price went up +0.3% vs S&P500 -0.4%

------------------------------------------------

2025-03-01

#reports #RPID

[Rapid Micro Biosystems, Inc.](https://eninvs.com/all.php?name=RPID) (Medical Devices) reported for 2024 q4
(2025-02-28, Before Market Open):

- Revenue +33.3% YoY (vs +33.3% in previous quarter and historical rate +10.8%)
- EBITDA margin -125.0% increased compared to -200.0% same period last year
- Net Debt increased by $9 mln over the past reporting period (6.8% of market cap)
- FCF (LTM) -$0 bln (negative), 23.3% of market cap
- EV/Sales multiple is 3x

At the opening of the session the share price went down -15.7% vs S&P500 -0.3%

------------------------------------------------

2025-03-01

#reports #PX

[P10, Inc.](https://eninvs.com/all.php?name=PX) (Asset Management) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=181617)
(2025-02-12, Before Market Open):

- Revenue +34.9% YoY (vs +25.4% in previous quarter and historical rate +25.2%)
- Net Income margin 2.4% increased compared to -6.3% same period last year
- P/E multiple is 54.9x compared to historical level (75th percentile) of 78.3x
- P/S multiple is 5x
- Price to book: 4.2x

At the opening of the session the share price went down -1.1% vs S&P500 -0.7%

Switch to company model in "Rising Stars" logic    *